Get it on Google Play

EMA validates Pfizer and Valneva's Lyme disease vaccine application

August 14, 2026 1:00 AM EDT Send to a Friend
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) announced that the European Medicines Agency (EMA) has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login